Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
19/03/2026
The State Council has approved and agreed to designate Meishan City in Sichuan Province as a national historical and cultural city.
Latest
4 m ago
Bosun Technology: Plans to publicly list and transfer the controlling stake of its subsidiary Chengdu Dongsheng Packaging Materials Co., Ltd., owning 51% of the shares.
4 m ago
The experimental drug "Ritatide" from Lilly Company for the treatment of obesity has shown weight loss effects superior to any other drug currently on the market, highlighting the potential of this drug in the increasingly fierce competition of next-generation therapies. Lilly Company announced on Thursday that patients taking the highest dose of Ritatide (including those who discontinued treatment) had an average weight loss of 15.3%. These late-stage trial results were significantly better than the company's previous diabetes blockbuster drug "Mufenda". Lilly stated that weekly injections of this injectable can lower blood sugar by 1.9% over approximately nine months, a similar effect to the approved "Mufenda" in 2022. "Ritatide" is one of the core strategies in Lilly Company's obesity treatment plan, with analysts estimating its sales could exceed $10.6 billion by 2036.
5 m ago
Global Happiness Index Report Released: Attention Drawn to the Impact of Social Media on Adolescent Happiness
5 m ago
A secure source reported that the headquarters of the Iraqi People's Mobilization Forces, located south of Kirkuk, was hit by an airstrike, with thick smoke rising from the site.
5 m ago
The preliminary ship loading plan shows that Angola plans to load 34 oil tankers in May and 28 tankers in April.
See all latest
